Trying gain w/O typos!!!
I think what IMM is (has been) short on, is a *business* plan, and MV (CEO/CFO) needs to put the focus on that, and not resting/relying on *clinical* plan. The business plan needs to lead, not lag, the clinical plan/progress. If there is *such* business plan, then CEO needs to market that with a focus on *it*, instead of the same every time, highlighting clinical status/progress in every interview.
Other possibility is that there may be mehod in maddness, keeping MC low, while us Aussie SHs funding the company and then bang, an (provided ?) opportunistic undervalued "T/O" ...
Trying gain w/O typos!!!I think what IMM is (has been) short on,...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.020(4.60%) |
Mkt cap ! $540.9M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 45.5¢ | 43.0¢ | $439.6K | 992.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 65958 | 3 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
44.8¢ |
Change
0.020 ( 3.21 %) |
||||
| Open | High | Low | Volume | ||
| 44.0¢ | 45.0¢ | 43.0¢ | 240557 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| IMM (ASX) Chart |